StockData
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp (BGLC) stock

BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 19, 2026Score 4/30
$0.68+0.00 (0.00%)

Close on Nov 20, 2026Market cap $1.99MP/E –Yield –

BioNexus Gene Lab shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioNexus Gene Lab's shares outstanding was 3M at Sep 30, 2026. For fiscal 2024 it was 18M, up 12.2% from the year before. The highest annual figure on record is 103M in fiscal 2020.

Annual shares outstanding

PeriodPeriod endValueChange
FY2024Dec 31, 202418M+12.2%
FY2023Dec 31, 202316M-84.6%
FY2020Dec 31, 2020103M+19.2%
FY2019Dec 31, 201986M+30.2%
FY2018Dec 31, 201866M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 20263M+49.9%
Q2 FY2026Jun 30, 20262M+34.5%
Q1 FY2026Mar 31, 20262M+34.5%
Q3 FY2025Sep 30, 20252M+1.7%
Q2 FY2025Jun 30, 20252M-89.8%
Q1 FY2025Mar 31, 20252M-99.0%
Q3 FY2024Sep 30, 20242M-99.0%
Q2 FY2024Jun 30, 20242M-99.0%
Q1 FY2024Mar 31, 202418M-82.9%
Q3 FY2021Sep 30, 2021171M+66.7%
Q2 FY2021Jun 30, 2021171M+66.7%
Q1 FY2021Mar 31, 2021171M+66.7%
Q4 FY2020Dec 31, 2020103M-1.1%
Q3 FY2020Sep 30, 2020103M+28.0%
Q2 FY2020Jun 30, 2020103M+37.6%
Q1 FY2020Mar 31, 2020103M+37.6%
Q4 FY2019Dec 31, 2019105M+65.5%
Q3 FY2019Sep 30, 201980M+19.2%
Q2 FY2019Jun 30, 201975M–
Q1 FY2019Mar 31, 201975M–
Q4 FY2018Dec 31, 201863M–
Q3 FY2018Sep 30, 201867M–

More BioNexus Gene Lab figures

See a number that looks wrong?